Dr. Alan S. Livingstone, MD

Dr. Livingstone practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Livingstone's NPI, 1306801808, was assigned on April 18, 2006. Dr. Livingstone graduated from McGill University Faculty of Medicine in 1971. Dr. Livingstone holds Florida license ME26728.

Dr. Livingstone's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Livingstone's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Livingstone is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Livingstone to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Livingstone practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Livingstone's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Livingstone is board certified in surgery by the American Board of Surgery. Dr. Livingstone is licensed in Florida.

Dmand AI lists colon removal, esophagus, stomach, or upper small intestine surgery and gastrointestinal bleeding among the conditions Dr. Livingstone treats.

CMS data shows 124 Medicare services from Dr. Livingstone across 3 procedure codes in 2024, all of them office visits, for 93 Medicare patients. Medicare paid $14,684 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Livingstone in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Livingstone's median patient age at 70, with 47% women.

In 2024, Dr. Livingstone wrote 76 Medicare Part D claims for 36 patients. 66% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $32,834 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Livingstone for performance year 2024, reported as part of a group. Dr. Livingstone accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 241 papers to Dr. Livingstone, published from 2005 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Postoperative Complications, Esophageal Neoplasms and Florida. Dr. Livingstone has published most often in Am Surg. Dr. Livingstone's most frequent co-authors are Dido Franceschi, MD, Joe U. Levi, MD and Danny Sleeman, MD.

Dmand AI links Dr. Livingstone to 2 clinical trials. Conditions studied include Esophageal Neoplasms and Esophageal Diseases. University of Miami sponsors the most, 2.

CMS Open Payments shows 48 general payments to Dr. Livingstone from 13 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Dilon Technologies, Inc. paid the most, $332.

Dmand AI lists 51 awards for Dr. Livingstone, most recently Duane G. Hutson Lifetime Achievement Award in Education in 2014.

Dr. Livingstone graduated from McGill University Faculty of Medicine in 1971. Dr. Livingstone is a member of ACS, SSAT, SLS and SSO.

Dr. Livingstone is in network with 11 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.